OncoSil Medical Limited (OSL.AX)
AUD 0.01
(-14.29%)
AUD 0.01
(-14.29%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.82 Million | -11.31 Million | -10.11 Million | -8.81 Million | -4.45 Million | -7.5 Million |
| Net Income | -11.91 Million | -11.34 Million | -10.72 Million | -10.43 Million | -4.26 Million | -8.56 Million |
| Depreciation & Amortization | 43.99 Thousand | 175.88 Thousand | 126.9 Thousand | 184.77 Thousand | 149.28 Thousand | 38.61 Thousand |
| Deferred income taxes | - | -1.19 Million | -647.72 Thousand | -306.76 Thousand | 3.1 Million | -1.07 Million |
| Stock-based compensation | 615.25 Thousand | 385.6 Thousand | 593.3 Thousand | -140.8 Thousand | -2.39 Million | 1.13 Million |
| Change in working capital | 31 Thousand | -531.64 Thousand | -255.91 Thousand | 1.46 Million | 2.04 Million | -60.2 Thousand |
| Other non-cash items | 399.04 Thousand | 1.19 Million | 799.94 Thousand | 416.19 Thousand | -3.1 Million | 1.02 Million |
| Investing Cash Flow | -197.06 Thousand | -57.81 Thousand | -5832.00 | -54 Thousand | -20.72 Thousand | -14.82 Thousand |
| Investments in PPE | -197.06 Thousand | -57.81 Thousand | -5832.00 | -54 Thousand | -20.72 Thousand | -14.82 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 6.12 Million | 9.48 Million | 9.15 Million | 111.25 Thousand | 17.78 Million | - |
| Debt repayment | -60.4 Thousand | -187.21 Thousand | -160.22 Thousand | -26.56 Thousand | -26.56 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -1.21 Million | - |
| Common Stock Issuance | 6.42 Million | 9.67 Million | 9.31 Million | 260 Thousand | 17.88 Million | - |
| Other Financing Activities | 6.18 Million | -187.21 Thousand | -160.22 Thousand | -122.18 Thousand | 17.83 Million | - |
| Accounts receivables | 45.82 Thousand | -377.93 Thousand | 273.7 Thousand | -28.69 Thousand | - | - |
| Accounts payables | 471.25 Thousand | -78.53 Thousand | -74.3 Thousand | -49.31 Thousand | 1.01 Million | -816.44 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -14.81 Thousand | -75.16 Thousand | -455.31 Thousand | 1.54 Million | 1.03 Million | 756.23 Thousand |
| Cash at beginning of period | 9.39 Million | 11.27 Million | 12.23 Million | 20.99 Million | 7.68 Million | 15.2 Million |
| Cash at end of period | 4.5 Million | 9.39 Million | 11.27 Million | 12.23 Million | 20.99 Million | 7.68 Million |
| Capital Expenditure | -197.06 Thousand | -57.81 Thousand | -5832.00 | -54 Thousand | -20.72 Thousand | -14.82 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -4.89 Million | -1.88 Million | -959.99 Thousand | -8.75 Million | 13.3 Million | -7.51 Million |
| Free Cash Flow | -11.02 Million | -11.37 Million | -10.11 Million | -8.86 Million | -4.47 Million | -7.51 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.89 Million | -12.37 Million | -6.01 Million | -5.69 Million | -11.34 Million | -5.65 Million |
| Depreciation & Amortization | -40.13 Thousand | 43.99 Thousand | 84.13 Thousand | 86.14 Thousand | 175.88 Thousand | 89.74 Thousand |
| Deferred income taxes | - | - | - | 65.67 Thousand | -1.19 Million | - |
| Stock-based compensation | 385.37 Thousand | - | 229.87 Thousand | 139.97 Thousand | 385.6 Thousand | 245.62 Thousand |
| Change in working capital | 31 Thousand | - | - | -453.1 Thousand | -531.64 Thousand | - |
| Other non-cash items | -996.75 Thousand | 1.29 Million | 1.79 Million | -133.52 Thousand | 1.19 Million | 336.7 Thousand |
| Investing Cash Flow | -197.06 Thousand | - | 9.39 Million | -54.52 Thousand | -57.81 Thousand | -3296.00 |
| Investments in PPE | -197.06 Thousand | - | - | -54.52 Thousand | -57.81 Thousand | -3296.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 6.3 Million | 6.23 Million | -175.9 Thousand | 9.6 Million | 9.48 Million | -114.51 Thousand |
| Debt repayment | - | - | -159.07 Thousand | - | -187.21 Thousand | -81.45 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 6.44 Million | 6.42 Million | -16.82 Thousand | 9.7 Million | 9.67 Million | -33.06 Thousand |
| Other Financing Activities | 6.3 Million | - | -16.82 Thousand | 9.6 Million | -187.21 Thousand | -33.06 Thousand |
| Accounts receivables | 45.82 Thousand | - | - | -377.93 Thousand | -377.93 Thousand | - |
| Accounts payables | - | - | - | - | -78.53 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -14.81 Thousand | - | - | -75.16 Thousand | -75.16 Thousand | - |
| Cash at beginning of period | 4.89 Million | 9.39 Million | 9.39 Million | 5.75 Million | 11.27 Million | 11.27 Million |
| Cash at end of period | 4.5 Million | 4.5 Million | 4.89 Million | 9.39 Million | 9.39 Million | 5.75 Million |
| Capital Expenditure | -197.06 Thousand | - | - | -54.52 Thousand | -57.81 Thousand | -3296.00 |
| Effect of forex changes on cash | 19 Thousand | - | -19 Thousand | -9.39 Million | - | 11.27 Million |
| Net cash flow / Change in cash | -390.48 Thousand | -4.89 Million | -4.5 Million | 3.63 Million | -1.88 Million | -5.52 Million |
| Free Cash Flow | -6.71 Million | -11.12 Million | -4.3 Million | -5.96 Million | -11.37 Million | -5.4 Million |
558
GPMTF
2845
MIS
KTN
LT